More information: Bo Tian et al, Dysregulated inclusion of BOLA3 exon 3 promoted by HNRNPC accelerates the progression of esophageal squamous cell carcinoma, Frontiers of Medicine (2024). DOI: 10. ...

Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up ...

esophageal adenocarcinoma and high-grade dysplasia in this fashion," says senior study author Stephen Meltzer, M.D., professor of medicine and oncology and the Harry and Betty Myerberg/Thomas R.

The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative ...

esophageal adenocarcinoma and high-grade dysplasia in this fashion," says senior study author Stephen Meltzer, M.D., professor of medicine and oncology and the Harry and Betty Myerberg/Thomas R.

Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment locally at low-volume centers, according to results of a cohort ...

Exploring the role of bispecific and CAR-T cell therapies in gastric cancer: A systematic review and meta-analysis. Identification of candidate biomarkers for gastric cancer by bioinformatics analysis ...

A dose-response relationship exists between body mass index (BMI) and esophageal adenocarcinoma (EAC) or high-grade dysplasia (HGD), the authors found. “Obesity has been implicated in the ...

The incidence of adenocarcinoma of the esophagus in white men has been rising rapidly, both in the United States and Europe, and has been linked to BE. Before adenocarcinoma of the esophagus ...